PuraPharm Corporation Limited announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was HKD 695.879 million compared to HKD 745.503 million a year ago. Net loss was HKD 227.258 million compared to net income of HKD 20.806 million a year ago. Basic loss per share was HKD 0.8716 compared to basic earnings per share of HKD 0.0816 a year ago. Diluted loss per share was HKD 0.8716 compared to diluted earnings per share of HKD 0.0811 a year ago.